ConductScience.org, home

Paper56916

Inhibition of dihydrostreptomycin binding to Mycobacterium smegmatis by monovalent and divalent cation salts.

Beggs WH and 1 other. Antimicrob Agents Chemother, 1976. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Inhibition of dihydrostreptomycin binding to Mycobacterium smegmatis by monovalent and divalent cation salts. Papers, record 56916. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/56916

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of dihydrostreptomycin binding to Mycobacterium smegmatis by monovalent and divalent cation salts.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.53
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Beggs WHW H
2Andrews FAF A

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Dihydrostreptomycin SulfateMajor topic
MagnesiumMajor topic
MycobacteriumMajor topic
Sodium ChlorideMajor topic
StrontiumMajor topic
Chlorides
Drug Antagonism

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15001629Effect of the concentrations of magnesium and calcium on the in-vitro susceptibility of Pseudomonas aeruginosa to gentamicin.J Infect Dis1971https://conductscience.org/library/papers/5001629PubMed
25001630Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin.J Infect Dis1971https://conductscience.org/library/papers/5001630PubMed
35330786The intracellular accumulation of 14-C-streptomycin by Escherichia coli strain B in relation to its growth-inhibitory effect.J Gen Microbiol1966https://conductscience.org/library/papers/5330786PubMed
413793254Uptake of streptomycin by Escherichia coli.Nature1960https://conductscience.org/library/papers/13793254PubMed
514071591THE SEQUENCE OF SOME EFFECTS OF STREPTOMYCIN IN ESCHERICHIA COLI.Biochim Biophys Acta1963https://conductscience.org/library/papers/14071591PubMed
614450179Accumulation of label from C14-streptomycin by Escherichia coli.J Bacteriol1962https://conductscience.org/library/papers/14450179PubMed
714487240Influence of salts on the uptake of streptomycin by Escherichia coli.Nature1961https://conductscience.org/library/papers/14487240PubMed
816558002Protection of Mycobacterium smegmatis from Ethambutol and Streptomycin Inhibition by MgSO(4) and Polyamines.Infect Immun1971https://conductscience.org/library/papers/16558002PubMed
1150048Inhibition of dihydrostreptomycin action on Mycobacterium smegmatis by monovalent and divalent cation salts.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/50048PubMed
121124316Nonspecificity in the divalent cation antagonism of dihydrostreptomycin action on Mycobacterium smegmatis.Res Commun Chem Pathol Pharmacol1975https://conductscience.org/library/papers/1124316PubMed
131137375Effects of divalent cations on binding of aminoglycoside antibiotics to human serum proteins and to bacteria.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1137375PubMed
144196445Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism.J Infect Dis1973https://conductscience.org/library/papers/4196445PubMed
154840434Chemical characterization of ethambutol binding to Mycobacterium smegmatis.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4840434PubMed
164963783Mechanism for the pyridoxal neutralization of isoniazid action of Mycobacterium tuberculosis.J Bacteriol1967https://conductscience.org/library/papers/4963783PubMed
174995852Streptomycin uptake by Mycobacterium tuberculosis.Appl Microbiol1971https://conductscience.org/library/papers/4995852PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
24532601Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.J Infect Dis2014https://conductscience.org/library/papers/24532601PubMed
7081982Gentamicin does not chelate calcium.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7081982PubMed
143238Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/143238PubMed
117280Bacillus subtilis mutants dependent on streptomycin.Mol Gen Genet1979https://conductscience.org/library/papers/117280PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/56916

GET https://conductscience.org/api/papers/v1/56916/authors